Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Anaptysbio (ANAB) FCF Margin (2016 - 2025)

Anaptysbio (ANAB) has disclosed FCF Margin for 10 consecutive years, with 90.45% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, FCF Margin rose 35855.0% year-over-year to 90.45%, compared with a TTM value of 9.42% through Dec 2025, up 24277.0%, and an annual FY2025 reading of 8.36%, up 15702.0% over the prior year.
  • FCF Margin was 90.45% for Q4 2025 at Anaptysbio, up from 54.56% in the prior quarter.
  • Across five years, FCF Margin topped out at 95.6% in Q2 2021 and bottomed at 2503.96% in Q4 2021.
  • Average FCF Margin over 5 years is 684.73%, with a median of 250.36% recorded in 2021.
  • The sharpest move saw FCF Margin plummeted -255720bps in 2021, then surged 228676bps in 2022.
  • Year by year, FCF Margin stood at 2503.96% in 2021, then surged by 91bps to 217.2% in 2022, then plummeted by -77bps to 384.55% in 2023, then skyrocketed by 30bps to 268.1% in 2024, then skyrocketed by 134bps to 90.45% in 2025.
  • Business Quant data shows FCF Margin for ANAB at 90.45% in Q4 2025, 54.56% in Q3 2025, and 181.05% in Q2 2025.